HRL
35
-3
NOC
41
9
ADBE
47
-9
URI
60
-6
AVGO
18
-9
MAS
52
-4
XYL
35
-2
CRM
60
-7
LLY
28
-8
WDC
37
-3
STX
45
-4
BDX
56
10
YUM
43
-6
DHR
32
-6
NEM
40
3
MTB
65
-2
FMC
23
-3
HRB
59
2
DLTR
38
-4
SWKS
38
-2
HRL
35
-3
NOC
41
9
ADBE
47
-9
URI
60
-6
AVGO
18
-9
MAS
52
-4
XYL
35
-2
CRM
60
-7
LLY
28
-8
WDC
37
-3
STX
45
-4
BDX
56
10
YUM
43
-6
DHR
32
-6
NEM
40
3
MTB
65
-2
FMC
23
-3
HRB
59
2
DLTR
38
-4
SWKS
38
-2
Financhill
Back

iShares US & Intl High Yield Corp Bd ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
38

GHYG
iShares US & Intl High Yield Corp Bd ETF

Last Price:
44.57
Seasonality Move:
0.36%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
38
iShares US & Intl High Yield Corp Bd ETF (GHYG) is a Sell

Is iShares US & Intl High Yield Corp Bd ETF a Buy, Sell or Hold?

  • The current iShares US & Intl High Yield Corp Bd ETF [GHYG] share price is $44.56. The Score for GHYG is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • GHYG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GHYG Stock Price Chart

What is iShares US & Intl High Yield Corp Bd ETF's stock price today?

  • The iShares US & Intl High Yield Corp Bd ETF share price today is $44.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GHYG is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

GHYG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 37.39 Sell
Chaikin Money Flow: -13971 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.74 - 45.1) Sell
Bollinger Bands (100): (44.29 - 45.35) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

GHYG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.78 Sell
20-day SMA: 44.86 Sell
50-day SMA: 45.15 Sell
200-day SMA: 44.29 Buy
8-day EMA: 44.73 Sell
20-day EMA: 44.87 Sell
50-day EMA: 44.96 Sell
200-day EMA: 44.33 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

iShares US & Intl High Yield Corp Bd ETF Earnings Growth & GHYG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

iShares US & Intl High Yield Corp Bd ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):